FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for a combined olanzapine and fluoxetine product, submitted by Par Health USA, LLC (brand name Symbyax).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Drugs mentioned

• Symbyax (olanzapine and fluoxetine)

Snippet

SUPPL AP for OLANZAPINE AND FLUOXETINE (OLANZAPINE AND FUOXETINE)